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Expression of GJB2 and GJB6 Is Reduced in a Novel DFNB1 Allele
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In a large kindred of German descent, we found a novel allele that segregates with deafness when present in trans with
the 35delG allele of GJB2. Qualitative polymerase chain reaction–based allele-specific expression assays showed that
expression of both GJB2 and GJB6 from the novel allele is dramatically reduced. This is the first evidence of a deafness-
associated regulatory mutation of GJB2 and of potential coregulation of GJB2 and GJB6.
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Mutations in GJB2, the gene encoding gap junction pro-
tein connexin 26 (Cx26), are the most common cause of
prelingual-onset, recessively inherited, nonsyndromic,
sensorineural hearing loss (SNHL) in humans. GJB2 and
GJB6, which encodes connexin 30 (Cx30), comprise the
DFNB1/A3 locus at 13q12 (fig. 1). In the vertebrate coch-
lea, Cx26 and Cx30 are coexpressed as heteromeric con-
nexons in nonsensory cells of the organ of Corti as well
as in subsets of cells of the spiral ligament and stria vas-
cularis1–3 and are implicated in the maintenance of coch-
lear K gradients necessary for proper hair-cell function.4,5
More than 80 recessive mutations of GJB2, nearly all
affecting proper translation of the Cx26 protein, and sev-
eral dominant missense mutations are implicated in
DFNB1/A3 hearing loss. Others cause skin disease with
accompanying SNHL, including Vohwinkel syndrome
(MIM 124500), Bart-Pumphrey syndrome (MIM 149200),
palmoplantar keratoderma, with deafness (PPK [MIM
148350]), and keratitis-ichthyosis-deafness (KID [MIM
148210]). Three dominant missense mutations of GJB6
have been shown to cause the skin disorder Clouston syn-
drome (hidrotic ectodermal dysplasia [MIM 129500]).
In contrast to the abundance and diversity of GJB2 hear-
ing-loss mutations, only a single dominant mutation of
GJB6 causing nonsyndromic hearing loss had been pub-
lished6 before the identification of two large deletions—
of 309 kb and 232 kb: del(GJB6-D13S1830) and del(GJB6-
D13S1854), respectively—truncating the 5′ end of GJB6
(fig. 1). These deletions segregate with hearing loss when
present homozygously or heterozygously with each other
or in trans with a recessive GJB2 mutation.7–11 Investigators
have suggested, but have not demonstrated, that loss of
appropriate regulation of GJB2 from chromosomes bear-
ing these deletions may underlie the hearing loss in these
individuals,7–11 which may be exacerbated by loss of one
GJB6 allele. Common et al.12 showed immunohistochem-
ical evidence that Cx26 expression is disrupted in certain
skin-cell types in an individual bearing the larger deletion
in trans with GJB2 35delG, suggesting disruption of a GJB2
cis-regulatory element located within this deleted interval.
Mutation screening of GJB2 in individuals whose hearing
loss and family history are consistent with GJB2 deafness
reveals a significant number of subjects with only one
identified mutation. Additional screening for GJB6 dele-
tions explains only some of these heterozygotes.
We report here evidence of a novel pathogenic DFNB1
allele for which we demonstrate reduction in or loss of
detectable expression of message from both GJB2 and
GJB6. Figure 2 shows a small portion of the pedigree of
MSU-DF5, a large American kindred of mainly German
descent. After obtaining written informed consent, we col-
lected DNA and performed audiological testing on 1200
family members. We screened all samples for GJB2 35delG
and for SLC26A4 L445W. Ten MSU-DF5 family members
are hearing impaired due to homozygosity of 35delG (one,
DF5-68, is shown in fig. 2); one deaf family member has
received a diagnosis of Pendred syndrome (MIM 274600)
and is homozygous for SLC26A4 L445W (not shown in
pedigree). Microsatellite and SNP genotyping across the
GJB2/GJB6 genomic region (fig. 1 and table 1) allowed us
to define a number of haplotypes. Three distinct haplo-
types bearing 35delG exist within the family, indicating
more than one founder for 35delG in this community
(two 35delG haplotypes appear in fig. 2). Notably, four
deaf family members, DF5-20, -70, -122, and -194, are het-
erozygous for 35delG and share a common haplotype (in-
dicated in fig. 2 by a black bar with a star) that is longer
than 600 kb and shorter than 3.1 Mb on their non-35delG
chromosome. These individuals are profoundly hearing
impaired, in contrast to DF5-68, who is homozygous for
35delG and the father of DF5-70 (fig. 3). Of the 14 family
members who carry the novel allele, all those with 35delG
on their other chromosome (4 individuals) have hearing
loss, whereas all those with any other allele (10 individ-
uals) have normal hearing ( , by Fisher’s exact test).P ! .001
We also performed a linkage analysis (easyLINKAGE Plus
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Figure 1. Map encompassing haplotyped region of 13q11-12, showing locations of GJB2, GJB6, genotyped microsatellite and SNP
markers, and breakpoints of del(GJB6-D13S1830) and del(GJB6-D13S1854), all shown approximately to scale. The locations of the
variants used for allele-specific expression assays—GJB2 35delG, GJB2 94, and rs7333214—are also indicated. Boxes indicate exons,
and the hatched boxes indicate the coding regions of the two genes. Vertical lines show approximate locations of genotyped micro-
satellites (in bold) and SNPs. D13S232 is the most proximal microsatellite showing recombination of the novel haplotype in affected
individuals. The transcriptional start sites of GJB2 and GJB6 are indicated by right-angled arrows.
Figure 2. A small portion of the MSU-DF5 pedigree, with DFNB1
haplotypes indicated for selected individuals. Five individuals with
congenital SNHL are represented by blackened symbols. One of
these, DF5-68, is hearing impaired because of homozygosity of
GJB2 35delG (DG). The other four are heterozygous for GJB2 35delG
and bear the same haplotype on their non-35delG chromosome
(black bar with star). Individuals contained within the boxed areas
were included in the linkage analysis.
Table 1. Selected Haplotype Assignments Based on
Genotypes at Microsatellites and SNPs in a 620-kb Region
of Chromosome 13 Including GJB2 and GJB6
Marker
Location
(bp)
Novel
DFNB1
Allele A B C D E
D13S1316 19,580,089-442 6 6 6 5 5.5 6
rs3751385 19,660,956 C T T C C C
35delG 19,661,685  DG DG   
rs9552098 19,662,895 C T T C C C
rs7994748 19,664,130 T C C T C T
GJB2 94 19,664,944 C C C A C C
SNP1245 19,665,308 T C C T C T
rs9509086 19,665,957 C A ND C A ND
rs9552102 19,668,529 T A ND T T ND
A21445T 19,673,593 A A A A T A
rs9552104 19,673,997 C G ND C C C
A19277T 19,675,761 A ND A ND T A
rs9315384 19,682,018 A G G A G A
rs7333214 19,694,497 C C C C A C
D13S175 19,746,380-734 4 3 3 2 4 2
rs13379006 19,795,790 T C C T C C
rs7337318 19,795,911 C G G C G G
rs13378957 19,795,932 A C C A C C
rs12873647 19,796,279 T C C T C C
rs9509139 19,796,316 A G G A G G
rs11616264 19,796,330 A T T A T T
rs944014 19,837,040 G A G G G G
rs9552241 20,025,569 ND ND G C G G
rs2772175 20,198,712 T T ND A A A
NOTE.—The “A” and “B” columns indicate delG (DG) alleles carried by
DF5-20 and DF5-70, respectively. The “C” column corresponds to the
haplotype shown by a box with stippling, “D” to the haplotype shown
by a box with horizontal lines, and “E” to the haplotype shown by a
white box in figures 2, 5, and 6. Locations are based on UCSC Genome
Browser, May 2004 assembly.  p wild type; ND p not determined.
v.3.01RC1, SuperLink v1.4) at the DFNB1 locus, using 28
individuals (shown in the boxed areas in fig. 2). We as-
signed the same mutant status to both the novel haplo-
type and the 35delG allele, and all other haplotypes were
considered nonmutant. The resulting LOD score of 2.08
indicates that there is a good likelihood that the novel
haplotype harbors a DFNB1 mutation.
We sequenced the entire coding regions and 5′ and 3′
UTRs of both GJB2 and GJB6 in three of our affected pro-
bands, including splice sites, alternative exons and pro-
moter regions, the entire single intron of GJB2, and several
kilobases of sequence around each gene, and found no
sequence variants unique to the novel haplotype. Hetero-
zygosities found in sequencing also showed that GJB2 and
GJB6 are intact on both chromosomes and that the af-
fected individuals do not bear either del(GJB6-D13S1830)
or del(GJB6-D13S1854). Southern blotting indicated no
rearrangements or unusual methylation around GJB2
(fig. 4).
We hypothesized that an unidentified cis-regulatory el-
ement of GJB2 exists within the DFNB1 locus and is dis-
rupted on our novel pathogenic allele. Given the imprac-
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Figure 3. Audiograms of four MSU-DF5 family members (identified by ID/sex/age). dB HLp decibels hearing level; ANSIp American
National Standards Institute. DF5-20, -70, and -122 are GJB2 35delG (35DG) heterozygotes bearing the novel pathogenic allele. Note
that all three have profound SNHL at all tested frequencies. By contrast, DF5-68, homozygous for GJB2 35delG and the father of DF5-
70, has significantly more residual hearing, particularly in his left ear. Although only pure-tone air-conduction thresholds are shown
(circle p right ear; # p left ear; arrows p threshold beyond tested limit), bone conduction thresholds and immittance measures
(not shown) indicate that the hearing loss in all four family members is sensorineural.
Figure 4. Southern blot of region around GJB2, in DF5-20 and
an unrelated control. The legend is available in its entirety in the
online edition of The American Journal of Human Genetics.
ticality of searching for candidate variants across the entire
locus, we first sought to acquire evidence of loss of GJB2
expression from this allele. We developed three allele-spe-
cific PCR assays to assess the relative abundance of tran-
script from each allele, using tissue both easily available
and expected to express Cx26. To isolate RNA, buccal cells
from several family members were collected on Cytosoft
brushes and were immediately stored in 1 ml Trizol
(Gibco/Life Technologies) on ice. Some samples were
stored at 20C for one to several days. RNA was isolated
after the Trizol protocol, was resuspended in 20 ml H2O,
and was stored at 80C. We followed a modified Super-
script II (Invitrogen) reverse-transcription protocol for
cDNA synthesis; 5–8 ml template RNA, 1 ml of 0.5 mg/ml
oligo(dT) primer, 1 ml of 10-mM dNTP, and 2 ml H2O were
heated to 70C for 10 min, were chilled on ice, and then
were mixed and incubated at 42C for 2 min after 4 ml of
5# first-strand buffer and 2 ml of 0.1-M dithiothreitol was
added. Addition of 1 ml Superscript II reverse transcriptase
was followed by incubation at 42C for 50 min and then
incubation at 70C for 15 min. A final incubation at 37C
for 20 min followed the addition of 1 ml RNaseH. A neg-
ative control to test for genomic DNA contamination was
generated for each sample by omitting the Superscript II
and replacing it with 1 ml H2O. These negative controls
were carried through the assays side by side with the cor-
responding sample. In no instance was product observed
for these controls (data not shown).
We designed a cDNA-specific PCR assay to assess the
relative abundance of 35delG and non-35delG product
amplified from GJB2 cDNA synthesized from 35delG het-
erozygotes (fig. 5A). A standard PCR-based assay for the
identification of 35delG in genomic DNA13 is based on the
introduction of a restriction site for BstNI by a 3′ mismatch
primer (5′-GCTGGTGGAGTGTTTGTTCACACCCGC-3′)
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Figure 5. Allele-specific expression assays for GJB2. A, Schematic showing design of BstNI (which assays for 35delG [35DG] genotype)
and BseYI (which assays for 94 genotype) digestion assay performed using 139-bp PCR product amplified from cDNA only. A forward
primer (F) located in the first, noncoding exon of GJB2 is separated on genomic DNA from the reverse mismatch primer (R), located
in the coding region of GJB2, by a 13-kb intron (F’ p forward primer for genomic 35delG assay). The BstNI site is introduced into
product amplified from wild-type (non-35delG [indicated by “”]) template. B and D, Pedigrees including DF5-70 and DF5-20, hetero-
zygous for both GJB2 35delG and the novel pathogenic allele (black bar with star). Also indicated are the 35delG and 94 genotypes.
C and E, Results of cDNA-specific assay for GJB2 expression based on 35delG genotype. Products of 139 bp were amplified from all
tested family members (ud p undigested, no enzyme added; d p addition of restriction enzyme). DF5-20, -70, and -71 (normal-
hearing sibling of DF5-70) are all heterozygous for 35delG; however, after digestion with BstNI, only DF5-71 clearly shows both 139-
bp and 110-bp products, indicating representation of two different alleles at the cDNA level. DF5-20 and DF5-70, who both bear the
novel pathogenic non-35delG allele, show either no or barely detectable 110-bp product, indicating underrepresentation of this allele
in the pool of amplified product (M p Marker V [Roche]). F, Results of cDNA-specific assay for GJB2 expression based on genotype at
GJB2 94. Products of 139 bp (ud p undigested) were amplified from both tested family members, who are both heterozygous (A/C)
at 94. Although the digested product (d) amplified from DF5-72 cDNA clearly indicates heterozygosity at the cDNA level, lack of any
detectable 139-bp product in the digested DF5-67 sample indicates underrepresentation of the novel (C) allele among the amplified
product.
that overlaps the run of Gs between nt 30 and nt 35. The
BstNI restriction site is present in PCR product amplified
from wild-type (non-35delG) alleles only and is absent in
PCR product amplified from 35delG alleles. We paired a
5′ primer located in exon 1 (5′-CGCAGAGACCCCAACGC-
CGAGA-3′) with the 3′ mismatch primer to generate a 139-
bp PCR product from cDNA template only, which, when
incubated with BstNI, will yield digestion products of 110
bp and 29 bp only if the 35delG mutation is not present.
For each individual we assayed, we amplified from cDNA
template and from the corresponding negative control. A
20-ml volume PCR (1–5 ml template cDNA, 2 ml 10#Qiagen
buffer, 4 ml Q solution (Qiagen), 0.16 ml of 25-mM dNTP
(Invitrogen), 1 ml of each 20-mM primer, 5 U Invitrogen
Taq DNA polymerase, and remainder H2O) was denatured
for 3 min at 94C, followed by 40 cycles at 94C for 30 s,
66C for 30 s, and 72C for 30 s, with a final extension at
72C for 5 min. Of each PCR, 10 ml was digested with ∼10
U BstNI (New England Biolabs) for 12 h, and 3 ml of each
reaction was run on a 3.5% NuSieve 3:1 agarose gel con-
taining 0.3 mg/ml ethidium bromide.
The results (fig. 5B–5E) for the two deaf 35delG hetero-
zygotes that we assayed, DF5-20 and DF5-70, indicate
that, although they are heterozygous for 35delG at the
genomic DNA level, the barely detectable or absent 110-
bp product indicates underrepresentation of GJB2 tran-
script from the novel (non-35delG) allele. Results from the
parents and sibling of DF5-70 are consistent with their
genotypes and provide appropriate controls. Unbiased
amplification and digestion of both 35delG and non-
35delG alleles is shown by the result for DF5-71, the sib-
ling of DF5-70, who is also heterozygous for 35delG but
carries a normal non-35delG chromosome. Sequencing of
genomic DNA across the 139-bp target sequence (not
shown) confirmed that there are no differences between
these two individuals that would give rise to a bias in
either amplification or digestion.
To demonstrate that loss of expression of this allele is
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Figure 6. Allele-specific expression assay for GJB6. A, Schematic
of design of HpyCH4IV digestion assay for allele-specific expression
of GJB6 mRNA performed using 1,550-bp PCR product amplified
from cDNA only. A forward primer (F) located in exon 5 of GJB6
is separated on genomic DNA from the reverse primer (R), located
in the GJB6 3′ UTR, by a 16-kb intron in addition to ∼1,500 bp
of the final exon. B, Pedigree showing rs7333214 genotypes of
assayed subjects. DF5-65 bears the novel pathogenic allele (black
bar with star) and is heterozygous at rs7333214. C, Results of cDNA-
specific assay for GJB6 expression. Digestion of product amplified
from DF5-72 yields 460-bp as well as 292- and 168-bp products,
indicating that both GJB6 alleles are expressed. Digestion of prod-
uct amplified from DF5-65 yields a robust 460-bp band, but the
band at 292 bp is only barely visible. This indicates underrepre-
sentation of the novel allele among the amplified product.
not unique to individuals carrying the 35delG mutation
on their other chromosome 13, we developed a second
assay to determine allele-specific GJB2 expression in a nor-
mal-hearing adult offspring of DF5-20 bearing the novel
haplotype (fig. 5A and 5D). DF5-67 carries a previously
unreported exon 1 SNP at position 94. BseYI digestion
of the 139-bp product amplified with the same primers as
described above will yield 102-bp and 27-bp products only
if an A is present at position 94 (10 ml of each PCR prod-
uct was digested with 5 U BseYI enzyme [New England
Biolabs] for 12 h, 5 ml of 1% SDS was added, and electro-
phoresis was performed as above). Although both DF5-67
and -72 are heterozygous for 94 at the genomic level,
all of the product amplified from DF5-67 cDNA was di-
gested (fig. 5F), indicating that no or very little of the PCR
product had been amplified from template derived from
the novel allele that bears the common variant, C. Again,
sequencing of genomic DNA across the target sequence
shows no differences between DF5-67 and DF5-72 that
would yield biased amplification or digestion of the re-
sulting amplimers.
We hypothesized that loss of expression of GJB2 might
be accompanied by loss of expression of GJB6, since these
two genes lie within 30 kb of each other and their products
are coexpressed in the cochlea. DF5-65, a normal-hearing
adult offspring of DF5-20, bears the novel haplotype and
is heterozygous for rs7333214 in the 3′ UTR of GJB6, al-
lowing us to test this hypothesis (fig. 6A and 6B). Using
a forward primer located in the fourth noncoding exon
(5′-CACCATTGGCTTCTAGGCAC-3′) and a reverse primer
located close to the 3′ end of the 3′ UTR (5′-CCACACTGTT-
CCGTCTACAT-3′), we amplified a 1,550-bp product from
cDNA template only, in a 20-ml PCR under the following
conditions: 2 ml of 10# Qiagen buffer, 4 ml Q solution
(Qiagen), 0.16 ml of 25-mM dNTP (Invitrogen), 1 ml of each
20-mM primer, 5 U Taq DNA polymerase (Invitrogen), and
remainder H2O were denatured for 5 min at 94C, followed
by 50 cycles at 94C for 30 s, 57C for 30 s, and 72C for
2 min, with a final extension at 72C for 5 min. Digestion
of this product for ∼2 h at 37C with ∼10 U HpyCH4IV
(New England Biolabs) yields digestion products of 537,
460, 338, and 214 bp if an A (the rare variant) is present
at rs7333214; the 460-bp product is digested to 292- and
168-bp products if a C is present at rs7333214 (the com-
mon variant, carried, in this case, on the novel allele).
Two microliters of each reaction was run on a 1.5% agarose
gel (10 mg ethidium bromide/30 ml) in 0.5# Tris-borate-
EDTA buffer. Comparison of the result for DF5-65 with
that for a control (DF5-72, his mother) who is also het-
erozygous for rs7333214 (fig. 6B) and whose DNA is iden-
tical across the target sequence, shows that the 292- and
168-bp products, derived from amplification of the novel
allele, are significantly underrepresented in DF5-65 (fig.
6C). This is consistent with the interpretation that ex-
pression of GJB6 as well as that of GJB2 is diminished from
the novel allele. Additionally, since the cDNA specificity
of each assay depends on the amplification of PCR product
from only cDNA from which a long intron has been prop-
erly spliced out, failure to accumulate PCR product might
also be expected from an allele that is mutant for proper
splicing. It is highly unlikely that GJB2 and GJB6 on this
chromosome both contain unidentified splice mutations.
This study provides evidence that the MSU-DF5 family
is segregating a novel DFNB1 allele that is characterized
by significant reduction in expression of both GJB2 and
GJB6. This loss of expression is heritable, cis-acting, and
not due to a simple parent-of-origin epigenetic modifi-
cation. We sought and found no coding-region mutations,
splice-site mutations, or any other sequence variant
unique to the novel allele within or close to GJB2 or GJB6,
suggesting that loss of function of an as-yet-unidentified
cis-regulatory element(s) is responsible for our observa-
tions. It is possible that a locus-control region (LCR) reg-
ulates the coexpression of GJB2 and GJB6. An LCR was
initially described in the b-globin locus, where it is ab-
solutely required for expression of any of the genes in this
cluster. Other examples include the growth hormone and
TH2 cytokine loci.
14 Such an element(s) may be located
within the common interval deleted on chromosomes
bearing del(GJB6-D13S1830) or del(GJB6-D13S1854). The
severity of hearing loss in the individuals in our kindred
who are heterozygous for 35delG and this novel allele
is similar to that in individuals who are del(GJB6-
D13S1830)/35delG, who as a group have been shown to
have more severe hearing loss than 35delG homozy-
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gotes.15 Beyond the identification of the basal promoters
of both genes,16–19 nothing is known of cis-acting elements
that regulate GJB2 and GJB6. The common observation of
an excess of deaf individuals bearing only a single iden-
tified GJB2 mutation strongly suggests that GJB2 regula-
tory mutations remain to be identified.
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